| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/16/2008 | EP1909911A1 Methods and compositions for improving pregnancy outcome |
| 04/16/2008 | EP1909910A1 Benzimidazole derivatives as sirtuin modulators |
| 04/16/2008 | EP1909895A2 Tandem cardiac pacemaker system |
| 04/16/2008 | EP1909841A2 Vaginal treatment composition |
| 04/16/2008 | EP1909840A1 Medicated gauze |
| 04/16/2008 | EP1909837A2 Compositions for treatment of systemic mastocytosis |
| 04/16/2008 | EP1909835A1 Methods and compositions for treating female infertility using clomiphene |
| 04/16/2008 | EP1909834A2 Use of hmgb1 antagonists for the treatment of inflammatory skin conditions |
| 04/16/2008 | EP1909816A2 Dermonecrotizing protein factors of bacterial origin and related uses in medical field |
| 04/16/2008 | EP1909812A2 Small compounds that correct protein misfolding and uses thereof |
| 04/16/2008 | EP1909804A1 Glucosamine and derivatives thereof useful as tg inhibitors |
| 04/16/2008 | EP1909803A2 Guanosine-rich oligonucleotides as agents for inducing cell death in eukaryotic cells |
| 04/16/2008 | EP1909802A2 Steroidal glycoside compounds as core 2 glcnac-t inhibitors |
| 04/16/2008 | EP1909801A2 Compostions containing pufa and/or uridine and methods of use thereof |
| 04/16/2008 | EP1909800A1 Acylglycerophospholipids for treating symptoms concomitant with cancer |
| 04/16/2008 | EP1909799A1 Oral contraception with trimegestone |
| 04/16/2008 | EP1909798A2 Oral suspension of prednisolone acetate |
| 04/16/2008 | EP1909796A1 Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to alleviate eye disorders |
| 04/16/2008 | EP1909795A1 Methods of identifying and treating individuals exhibiting mutant kit protein |
| 04/16/2008 | EP1909794A2 Combination of organic compounds |
| 04/16/2008 | EP1909793A2 Use of phosphodiesterase type 5 inhibitors for the prevention and treatment of diseases or health disorders and dispensing system for said inhibitors |
| 04/16/2008 | EP1909792A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 04/16/2008 | EP1909791A1 G-protein coupled receptor agonists |
| 04/16/2008 | EP1909790A1 Methods of dosing propofol prodrugs for inducing mild to moderate levels of sedation |
| 04/16/2008 | EP1909789A2 Antidiabetic oxazolidinediones and thiazolidinediones |
| 04/16/2008 | EP1909788A2 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 04/16/2008 | EP1909787A1 Tizanidine compositions and methods of treatment using the compositions |
| 04/16/2008 | EP1909786A2 TRICYCLIC 6-ALKYLIDENE-PENEM ß-LACTAMASE INHIBITORS AND ß-LACTAM ANTIBIOTIC COMBINATION: A BROAD SPECTRUM ANTIBIOTIC |
| 04/16/2008 | EP1909785A2 Use of progesterone receptor modulators |
| 04/16/2008 | EP1909784A1 Papain family cysteine protease inhibitors for the treatment of parasitic diseases |
| 04/16/2008 | EP1909783A2 Illudin analogs useful as anticancer agents |
| 04/16/2008 | EP1909782A2 Compositions comprising an no donor and a dithiolane and their use for improvement of sexual function |
| 04/16/2008 | EP1909781A1 Therapeutic combination comprising a nmda receptors blocker and a narcotic analgesic substance |
| 04/16/2008 | EP1909779A1 Thiol-sensitive positive inotropes |
| 04/16/2008 | EP1909778A1 Sensitization of immune system against haptenized melanoma antigens |
| 04/16/2008 | EP1909777A2 High drug load formulations and dosage forms |
| 04/16/2008 | EP1909776A2 Dodecylsulfate salt of a dipeptidyl peptidase-iv inhibitor |
| 04/16/2008 | EP1909775A2 Formulation of radioprotective alpha, beta unsaturated aryl sulfones |
| 04/16/2008 | EP1909774A2 Block copolymer compositions and uses thereof |
| 04/16/2008 | EP1909773A1 Transdermal system for varenicline |
| 04/16/2008 | EP1909772A1 Transdermal drug delivery formulation |
| 04/16/2008 | EP1909770A2 Oral controlled release composition containing levetiracetam |
| 04/16/2008 | EP1909769A2 Alcohol resistant pharmaceutical formulations |
| 04/16/2008 | EP1909768A1 Extended release solid pharmaceutical composition containing carbidopa and levodopa |
| 04/16/2008 | EP1909766A2 Pharmaceutical formulations/composition of guanfacine suitable for single dose form adminstration daily |
| 04/16/2008 | EP1909764A1 Pharmaceutical compositions comprising levetiracetam and process for their preparation |
| 04/16/2008 | EP1909763A2 Benzoquinones of enhanced bioavailability |
| 04/16/2008 | EP1909762A2 Amorphous efavirenz and the production thereof |
| 04/16/2008 | EP1909761A1 Pharmaceutical composition comprising granular pantoprazole |
| 04/16/2008 | EP1909760A1 Tocopheryl polyethylene glycol succinate powder and process for preparing same |
| 04/16/2008 | EP1909759A2 Sustained release of antiinfectives |
| 04/16/2008 | EP1909757A2 Oral liquid losartan compositions |
| 04/16/2008 | EP1909756A1 Pharmaceutical formulations of endo-n-(9- methyl-9-azabicyclo[3 .3.1]non-3-yl)-1-methyl-1h-indazole-3-carboxamide hydrochloride |
| 04/16/2008 | EP1909752A2 Modified-release pharmaceutical compositions |
| 04/16/2008 | EP1909744A2 Methods and compositions for reducing skin damage |
| 04/16/2008 | EP1909601A1 Liquid formulation based on a guanidinoacetic acid component |
| 04/16/2008 | EP1909578A2 Hiv integrase inhibitors |
| 04/16/2008 | EP1909575A2 Substituted n-cinnamyl benzamides |
| 04/16/2008 | EP1909573A2 Rapid onset and short term modafinil compositions and methods of use thereof |
| 04/16/2008 | EP1909572A2 Potassium channel inhibitors |
| 04/16/2008 | EP1851194A4 Process for preparation of probucol derivatives |
| 04/16/2008 | EP1833788B1 Process for preparing perindopril erbumine |
| 04/16/2008 | EP1799690B1 Thiazolyl-dihydro indazoles |
| 04/16/2008 | EP1789408B1 Androgen modulators |
| 04/16/2008 | EP1744742A4 Crystalline and amorphous forms of efaproxiral sodium |
| 04/16/2008 | EP1711492B1 Substituted quinolines and their use as mycobacterial inhibitors |
| 04/16/2008 | EP1680096B1 New formulation for retinoid-containing soft gelatin capsules |
| 04/16/2008 | EP1633376B1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc |
| 04/16/2008 | EP1581471B1 Cyclopentenone derivatives for cancer therapy |
| 04/16/2008 | EP1578727B1 Tetrahydroquinoline derivatives and their use as fsh receptor modulators |
| 04/16/2008 | EP1567526B1 Carbamic acid esters with anticholinergic action |
| 04/16/2008 | EP1556034B1 Indole derivatives as beta-2 agonists |
| 04/16/2008 | EP1551429A4 Antiseptic solutions containing silver chelated with polypectate and edta |
| 04/16/2008 | EP1545563B1 Composition and method for use in intestinal cleansing procedures |
| 04/16/2008 | EP1524988B1 Use of a proteasome inhibitor in the treatment of fibrotic diseases |
| 04/16/2008 | EP1476032B1 Coenzyme q10 formulation |
| 04/16/2008 | EP1440059B1 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists |
| 04/16/2008 | EP1423382B1 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/16/2008 | EP1401404B1 Method of encapsulating an active substance |
| 04/16/2008 | EP1361885B1 Use of gamma-gt inhibitors for the treatment of chronic degenerative diseases |
| 04/16/2008 | EP1309585B1 Novel indole derivatives and their use as medicaments |
| 04/16/2008 | EP1274735B1 Process for extraction of g(b)-glucan from cereals and products obtained therefrom |
| 04/16/2008 | EP1250434B1 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 04/16/2008 | EP1250155B1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/16/2008 | EP1222283B1 Dna immunization against chlamydia infection |
| 04/16/2008 | EP1189912B1 Novel crystalline forms of a macrolide antibiotic |
| 04/16/2008 | EP1165549B1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 04/16/2008 | EP1108039B1 Elongase genes and uses thereof |
| 04/16/2008 | EP0966275B1 Composition of a dietary product that is effective to combat oxidative stress and cell decay |
| 04/16/2008 | EP0885244B2 Peptide immunogens for vaccination against and treatment of allergy |
| 04/16/2008 | CN101163796A Cationic lipids and methods of use |
| 04/16/2008 | CN101163710A Phosphine transition metal complex, process for producing the same and anticancer drug containing the same |
| 04/16/2008 | CN101163707A Thienopyridines |
| 04/16/2008 | CN101163706A Dihydrothienopyrimidines for the treatment of inflammatory diseases |
| 04/16/2008 | CN101163705A Combination product |
| 04/16/2008 | CN101163704A Tadalafil having a large particle size and a process for preparation thereof |
| 04/16/2008 | CN101163703A Imidazo [1, 2-a]pyridine derivatives useful as peptide deformylase (pdf) inhibitors |
| 04/16/2008 | CN101163701A Quinolinone compounds as 5-ht4 receptor agonists |
| 04/16/2008 | CN101163700A 三胺衍生物 Triamine derivative |
| 04/16/2008 | CN101163697A Pyrrole derivatives as DNA gyrase and topoisomerase inhibitors |